This Solicitation opportunity from Department Of Defense was posted on May 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

SODIUM CHLORIDE INJ

Closed

SPE2DP-26-T-3299Federal

Submission Closed05/13/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

PLASMA-LYTE A INJECThe contract involves the procurement of PLASMA-LYTE A INJEC, identified by NSN 6505-01-708-9039, with a total quantity of three units requested under purchase request number 7017120906. The solicitation, designated SPE2DP-26-T-3802, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. The response deadline for the solicitation is June 22, 2026, indicating a brief window for submissions. This contract is categorized as a solicitation with no specified type of set-aside or applicable NAICS code, and the performance location details are not provided. The contracting agency is a federal entity focusing on defense logistics, ensuring the procurement supports government operations. Relevant contract information and updates are accessible via the Defense Logistics Agency's procurement platform.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by the National Stock Number 6505-01-718-3484. The request involves a quantity of five units under purchase request number 7013890090. This solicitation, numbered SPE2DP-26-T-3808, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The procurement is managed by the Defense Logistics Agency, a federal organization within the Department of Defense, and is intended for performance within the United States, although specific locations are not specified. This contract solicitation falls under federal acquisition and does not indicate any set-aside type or NAICS code, implying it may be open to all qualified bidders. The relevant information is accessible through the Defense Logistics Agency’s online portal, where potential vendors can review and respond to the request. Points of contact are not provided in the available data, indicating that interested parties may need to use the online platform for further inquiries.

Defense Logistics Agency

POSTED

DEADLINE

REHYDRATION SALTS FThe contract pertains to the procurement of rehydration salts, specifically identified by the NSN/Part Number 6505-01-731-2277, with a total quantity of 2 units requested under purchase request number 7015714540. The solicitation, titled "REHYRATION SALTS F," was issued by the Defense Logistics Agency, a component of the Department of Defense, on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. This federal solicitation lacks set-aside designations and NAICS code details, indicating it was open to all qualified bidders. The place of performance details were unspecified, suggesting flexibility or further clarification in subsequent communications. The contract focuses on meeting the agency's need for these medical supplies, likely for use in rehydration treatment scenarios, aligning with the Department of Defense's logistical and operational requirements.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by NSN/Part Number 6505-01-718-3478, with a purchase request quantity of five units. This solicitation, numbered SPE2DP-26-T-3803, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The contracting agency responsible for this procurement is the Defense Logistics Agency under the Department of Defense. This contract is a federal solicitation with no set-aside type indicated, and no specific NAICS code was assigned. While the precise location for the place of performance and the office address details are not provided, the procurement is handled within the United States. The contract is publicly available for review on the Defense Logistics Agency’s electronic bidding system, allowing eligible vendors to respond within the designated timeframe.

Defense Logistics Agency

POSTED

DEADLINE

PSYLLIUM HYDROPHILIThe contract pertains to the procurement of Psyllium Hydrophili, identified by the NSN/Part Number 6505-01-719-3181, with a purchase request for a quantity of three units. The solicitation, numbered SPE2DP-26-T-3801, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. It is a federal solicitation, with a response deadline set for June 22, 2026. The contract does not specify any set-aside type or NAICS code, and the exact location details for the office or place of performance are not provided. This solicitation is intended to acquire the specified product through a formal bidding process managed by a federal defense agency. Interested parties are able to access the solicitation and submit their responses through the Defense Logistics Agency’s bidding platform. The contract focuses on ensuring timely procurement within the established deadlines and under federal regulations relevant to government acquisitions.

Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

This contract covers the procurement of Sodium Chloride Injection, USP, specifically 0.9% solution in 1000 mL latex-free IV plastic bags packaged in units of 12. The product must be stored at controlled room temperature, protected from excessive heat, freezing, and incompatible materials, and complies with FDA regulations. Packaging and packing requirements follow DLA's commercial standards, ensuring each unit is securely sealed to prevent damage during transport. Marking must conform to Medical Marking Standard No. 1, overriding previous military standards. The contract stipulates that the shelf life is 30 months non-extendable for this Type I item. The contract is identified by solicitation number SPE2DP-26-T-3299, with delivery required within five days to Elkhorn, Nebraska, under destination delivery terms. The total order quantity is two packages, each containing 12 units, associated with National Stock Number 6505-01-330-6269. Inspection and acceptance will occur at the destination. The contract references multiple technical and quality requirements from the DLA master list and requires referral to product specialists prior to contract award. The primary point of contact for this procurement is Timothy McCauley from the Medical Supply Chain Pharmacy FSA under the Department of Defense.

General Info

Procurement of 0.9% Sodium Chloride Injection, 1000 mL bags, 24 units, delivered Nebraska.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers View NAICS

Place of Performance

9606 NORTH 204TH ST, ELKHORN, NE, 68022-3964, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3299.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedMay 7

Solicitation

Response DeadlineMay 13

Deadline has passed

Submission Closed

05/13/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

Timothy Mccauley

contact@example.gov

+1 (555) 000-0000

Full Description

SODIUM CHLORIDE INJ
SODIUM CHLORIDE INJECTION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
0.9% 1000ML IV PLASTIC BAG LATEX FREE. UNIT OF ISSUE (1) PACKAGE 12's. 1 PG = 12 EA Store at 20° to 25°C (68° to 77°F) USP Controlled Room Temperature Avoid excessive heat. Protect from freezing. Store away from Incompatible Materials This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-3299
SECTION B
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N NDC00264-5802-00 ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7983-09 B. BRAUN MEDICAL INC 11171 P/N Q8000
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016665123 0001 PG 2.000
NSN/MATERIAL:6505013306269
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-330-6269 Quantity: 2 PG Purchase Request: 7016665123QTY: 2 Delivery: 5 days ADO